Data-Driven Precision Medical Service Market Report 2025

The data-driven precision medical service market size has grown exponentially in recent years. It will grow from $137.51 billion in 2024 to $165.24 billion in 2025 at a compound annual growth rate (CAGR) of 20.2%. The growth during the historic period is linked to the increasing use of electronic health records, expanding demand for personalized treatments, broader integration of artificial intelligence in healthcare, heightened need for precise diagnostics, and the rise of healthcare data analytics initiatives.

The data-driven precision medical service market size is expected to see rapid growth in the next few years. It will grow to $340.44 billion in 2029 at a compound annual growth rate (CAGR) of 19.8%. The projected growth in the forecast period is driven by wider adoption of genomics and precision medicine, greater implementation of artificial intelligence and machine learning, increased demand for real-time patient monitoring, rising investments in healthcare data analytics, and a stronger emphasis on preventive and personalized care. Key trends in this period include improvements in artificial intelligence algorithms, innovations in genomic data interpretation, adoption of cloud-based healthcare platforms, enhancements in predictive analytics for patient outcomes, and advancements in personalized treatment planning.

The increasing use of cloud-based solutions is expected to drive the growth of the data-driven precision medical service market. Cloud solutions, including software, platforms, or infrastructure, are delivered through the internet, offering on-demand access, storage, and computing without requiring local installations. Their scalability is a key factor in this adoption, as they enable organizations to easily adjust computing resources based on demand without significant upfront investments. This flexibility supports real-time analysis of patient data, predictive modeling, and personalized care. According to Ace Cloud Hosting, a company specializing in cloud computing solutions for healthcare, 95% of healthcare organizations are using cloud technology for managing patient data. In 2025, cloud adoption in healthcare saw a 41% year-over-year increase, the highest among all industries. This surge in cloud adoption is expected to continue fueling the growth of the data-driven precision medical service market.

Major players are increasingly investing in innovations such as deep learning for multi-omics discovery to advance personalized treatment strategies, improve biomarker identification, and enhance clinical decision-making in areas such as oncology. This method leverages AI algorithms to analyze complex genomic, epigenomic, transcriptomic, and proteomic data, aiding in the discovery of new biomarkers and therapeutic targets. For example, in January 2023, Guardant Health, a biotechnology firm in the US, launched Guardant Galaxy, a suite of advanced analytical tools designed to enhance the precision and clinical relevance of its cancer testing portfolio. The platform integrates sophisticated analytics to support more accurate diagnostics and personalized treatment plans while accelerating the discovery of new biomarkers and drug targets, advancing the next generation of drug development.

In July 2025, Samsung Electronics, based in South Korea, acquired Xealth, a digital health platform provider, for an undisclosed amount. The acquisition aims to strengthen Samsung's connected care platform by combining wearable health data with Xealth's digital health orchestration system. This integration connects wellness tools with clinical decision workflows, improving patient care through seamless interaction with electronic health records. Xealth, a US-based company, specializes in providing data-driven solutions that help healthcare systems deliver precision medical services by integrating various digital health tools.

Major players in the data-driven precision medical service market are Samsung Electronics Co. Ltd., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., BioNTech SE, QIAGEN N.V., Natera Inc., Precision Medicine Group Inc., Guardant Health Inc., Tempus Labs Inc., Flatiron Health Inc., Certara L.P., Verily Life Sciences LLC, GenomOncology Inc., SOPHiA GENETICS SA, Recursion Pharmaceuticals Inc., DNAnexus Inc., Biomea Fusion Inc.

North America was the largest region in the data-driven precision medical service market in 2024. The regions covered in data-driven precision medical service report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the data-driven precision medical service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Data-driven precision medical service describes healthcare solutions that utilize patient-specific information, advanced computational tools, and analytics to provide highly individualized diagnosis, treatment, and preventive strategies. It combines genomic, clinical, and lifestyle data to enhance medical decisions and achieve better outcomes.

The primary forms of data-driven precision medical services are cloud-based and on-premises. Cloud-based solutions operate on secure platforms, offering scalable storage, immediate access, and advanced analysis of patient health information. These services employ technologies including artificial intelligence, machine learning, big data analytics, genomics and sequencing, cloud computing, blockchain, digital twin systems, wearable devices, and the Internet of Things (IoT). They are implemented in hospitals, clinics, and other healthcare environments, supporting more personalized, efficient, and data-driven care.

The data-driven precision medical services market research report is one of a series of new reports that provides data-driven precision medical services market statistics, including the data-driven precision medical services industry global market size, regional shares, competitors with the data-driven precision medical services market share, detailed data-driven precision medical services market segments, market trends, and opportunities, and any further data you may need to thrive in the data-driven precision medical services industry. This data-driven precision medical services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The data-driven precision medical service market includes revenues earned by entities through genomic-based services, predictive analytics services, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.